Latest Articles
Amy Schumer Opens Up About Taking Weight Loss Medications Again After Losing 30 Lbs ‘So Quick’ Last Time: ‘Mounjaro’s Been Great’ - SheFinds
Amy Schumer Opens Up About Taking Weight Loss Medications Again After Losing 30 Lbs ‘So Quick’ Last Time: ‘Mounjaro’s Been Great’ SheFinds
Published: March 26, 2025, 2 p.m.
Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets - The ASCO Post
Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets The ASCO Post
Published: March 24, 2025, 2:03 p.m.
Music, awareness and fundraising for endometriosis: Women-fronted Denton artists unite for benefit show - Denton Record Chronicle
Music, awareness and fundraising for endometriosis: Women-fronted Denton artists unite for benefit show Denton Record Chronicle
Published: March 23, 2025, 5:45 p.m.
Music, awareness and fundraising for endometriosis: Women-fronted Denton acts unite for benefit show - Denton Record Chronicle
Music, awareness and fundraising for endometriosis: Women-fronted Denton acts unite for benefit show Denton Record Chronicle
Published: March 23, 2025, 5:45 p.m.
Stoke-on-Trent City Council becomes endometriosis-friendly employer - Employee Benefits
Stoke-on-Trent City Council becomes endometriosis-friendly employer Employee Benefits
Published: March 21, 2025, 12:21 p.m.
Real-World Data Support Dostarlimab Combo Benefit in RUBY Trial - Cancer Network
Real-World Data Support Dostarlimab Combo Benefit in RUBY Trial Cancer Network
Published: March 20, 2025, 8:01 p.m.
Work and Pensions Secretary sets out overhaul of benefits system - Shropshire Star
Work and Pensions Secretary sets out overhaul of benefits system Shropshire Star
Published: March 18, 2025, 1:40 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - Oncology News Central
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups Oncology News Central
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - oncologynewscentral.com
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups oncologynewscentral.com
Published: March 18, 2025, 10:24 a.m.
Link copied to clipboard!